F
Frederick Klauschen
Researcher at Humboldt University of Berlin
Publications - 238
Citations - 17312
Frederick Klauschen is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 45, co-authored 170 publications receiving 12451 citations. Previous affiliations of Frederick Klauschen include Charité & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Morphological and molecular breast cancer profiling through explainable machine learning
Alexander Binder,Alexander Binder,Alexander Binder,Michael Bockmayr,Michael Bockmayr,Miriam Hägele,Stephan Wienert,Daniel Heim,Katharina Hellweg,Masaru Ishii,Albrecht Stenzinger,Andreas C. Hocke,Carsten Denkert,Klaus-Robert Müller,Frederick Klauschen +14 more
TL;DR: An explainable machine-learning approach for the integrated profiling of morphological, molecular and clinical features from breast cancer histology allows for the robust detection of cancer cells and tumour-infiltrating lymphocytes in histological images, and allows assessment of the link between morphological and molecular cancer properties.
Journal ArticleDOI
Epidermal γδ T cells originate from yolk sac hematopoiesis and clonally self-renew in the adult.
Rebecca Gentek,Clément Ghigo,Guillaume Hoeffel,Guillaume Hoeffel,Audrey Jorquera,Rasha Msallam,Stephan Wienert,Frederick Klauschen,Florent Ginhoux,Florent Ginhoux,Marc Bajénoff +10 more
TL;DR: DETCs resemble LCs concerning their maintenance, replenishment mechanisms, and hematopoietic development, suggesting that the epidermal microenvironment exerts a lineage-independent influence on the initial seeding and homeostatic maintenance of its resident immune cells.
Journal ArticleDOI
Subgroup-specific immune and stromal microenvironment in medulloblastoma.
Michael Bockmayr,Malte Mohme,Frederick Klauschen,Beate Winkler,Jan Budczies,Stefan Rutkowski,Ulrich Schüller +6 more
TL;DR: A mild, but subgroup-specific infiltration of immune cells in medulloblastoma is suggested, indicating distinct types of local tumor immunosuppression.
Journal ArticleDOI
Mutations in POLE and survival of colorectal cancer patients--link to disease stage and treatment.
Albrecht Stenzinger,Nicole Pfarr,Volker Endris,Roland Penzel,Lina Jansen,Thomas Wolf,Esther Herpel,Arne Warth,Frederick Klauschen,Matthias Kloor,Wilfried Roth,Hendrik Bläker,Jenny Chang-Claude,Hermann Brenner,Michael Hoffmeister,Wilko Weichert +15 more
TL;DR: POLE EDMs do not appear to define an entirely new clinically distinct disease entity in CRC but may have prognostic or predictive implications in CRC subgroups, whose significance remains to be investigated in future studies.
Journal ArticleDOI
Who is at risk for diagnostic discrepancies? Comparison of pre- and postmortal diagnoses in 1800 patients of 3 medical decades in East and West Berlin.
Daniel Wittschieber,Frederick Klauschen,Anna-Christin Kimmritz,Moritz von Winterfeld,Carsten Kamphues,Hans-Joachim Scholman,Andreas Erbersdobler,Heidi Pfeiffer,Carsten Denkert,Manfred Dietel,Wilko Weichert,Jan Budczies,Albrecht Stenzinger,Albrecht Stenzinger +13 more
TL;DR: A well-powered analysis revealed a significant rate of class-I-discrepancies indicating that autopsies are still of value, and identified risk profiles may aid both pathologists and clinicians to identify patients at increased risk for a discrepant diagnosis and possibly suboptimal treatment intra vitam.